United States
Germany
Japan
United Kingdom
China
CTNNB1 Mutant (T40I), Myc-DDK-tagged ORF clone of Homo sapiens catenin (cadherin-associated protein), beta 1, 88kDa (CTNNB1), transcript variant 1 as transfection-ready DNA
| Mutation | T40I |
| Tag | Myc-DDK |
| Vector | pCMV6-Entry |
- TrueORF®
Products
CTNNB1 Mutant (D32Y), Myc-DDK-tagged ORF clone of Homo sapiens catenin (cadherin-associated protein), beta 1, 88kDa (CTNNB1), transcript variant 1 as transfection-ready DNA
| Mutation | D32Y |
| Tag | Myc-DDK |
| Vector | pCMV6-Entry |
- TrueORF®
CTNNB1 Mutant (S45del), Myc-DDK-tagged ORF clone of Homo sapiens catenin (cadherin-associated protein), beta 1, 88kDa (CTNNB1), transcript variant 1 as transfection-ready DNA
| Mutation | S45del |
| Tag | Myc-DDK |
| Vector | pCMV6-Entry |
- TrueORF®
CTNNB1 Mutant (G34V), Myc-DDK-tagged ORF clone of Homo sapiens catenin (cadherin-associated protein), beta 1, 88kDa (CTNNB1), transcript variant 1 as transfection-ready DNA
| Mutation | G34V |
| Tag | Myc-DDK |
| Vector | pCMV6-Entry |
- TrueORF®
CTNNB1 Mutant (D32H), Myc-DDK-tagged ORF clone of Homo sapiens catenin (cadherin-associated protein), beta 1, 88kDa (CTNNB1), transcript variant 1 as transfection-ready DNA
| Mutation | D32H |
| Tag | Myc-DDK |
| Vector | pCMV6-Entry |
- TrueORF®
CTNNB1 Mutant (S45C), Myc-DDK-tagged ORF clone of Homo sapiens catenin (cadherin-associated protein), beta 1, 88kDa (CTNNB1), transcript variant 1 as transfection-ready DNA
| Mutation | S45C |
| Tag | Myc-DDK |
| Vector | pCMV6-Entry |
- TrueORF®
CNY 2,700.00
CNY 3,790.00
2周
CNY 3,990.00
2周
CNY 3,990.00
2周
CNY 3,990.00
2周
CNY 3,990.00
2周
CNY 3,990.00
2周
CNY 3,990.00
2周
CNY 3,990.00
2周
CTNNB1 mouse monoclonal antibody, clone OTI1H10 (formerly 1H10)
| Applications | IHC, WB |
| Reactivities | Human, Mouse, Rat |
活动过滤器
优化搜索结果
Species
Reactivities
Applications
Antibody Hosts
Expression Hosts
Lentivirus
Tags
Vectors
Knockout (KO) Validation
Conjugates
Modifications
Isotypes
Clonalities
Assay Types
Brands
QC Levels
Families
Pathways
- Adherens junction (242)
- Arrhythmogenic right ventricular cardiomyopathy (ARVC) (242)
- Basal cell carcinoma (242)
- Colorectal cancer (242)
- Endometrial cancer (242)
- Focal adhesion (242)
- Leukocyte transendothelial migration (242)
- Melanogenesis (242)
- Pathogenic Escherichia coli infection (242)
- Pathways in cancer (242)
- Prostate cancer (242)
- Thyroid cancer (242)
- Tight junction (242)
- Wnt signaling pathway (242)
